JNK-dependent AP-1 activation is required for aristolochic acid-induced TGF-β1 synthesis in human renal proximal epithelial cells

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 12, 2012, Pages

  Rui, Hong Liang ^a   Wang, Yan Yan ^a   Cheng, Hong ^a   Chen, Yi Pu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

C Jun; MEKK4; MKK4; MKK7; Transforming growth factor 1

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ARISTOLOCHIC ACID; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; PEPTIDES AND PROTEINS; PROTEIN C FOS; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR ACTIVATING PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY PROXIMAL EPITHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84862605096     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00560.2011     Document Type: Article

References (32)

1. Arlt VM, Stiborova M, vom Brocke J, Simoes ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 28: 2253-2261, 2007.
2. Bakhiya N, Arlt VM, Bahn A, Burckhardt G, Phillips DH, Glatt H. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy. Toxicology 264: 74-79, 2009.
3. Chen W, Chen Y, Li A. The clinical and pathological manifestations of aristolochic acid nephropathy-the report of 58 cases. Zhonghua Yi Xue Za Zhi 81: 1101-1105, 2001.
4. Cosyns JP. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Drug Saf 26: 33-48, 2003.
5. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74: 158-169, 2008.
6. de Jonge H, Vanrenterghem Y. Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy. Nephrol Dial Transplant 23: 39-41, 2008.
7. Fogo AB. Pathology of progressive nephropathies. Curr Opin Nephrol Hypertens 9: 241-246, 2000.
8. Fogo AB. The potential for regression of renal scarring. Curr Opin Nephrol Hypertens 12: 223-225, 2003.
9. Frey RS, Mulder KM. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 57: 628-633, 1997.
10. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelic M, Jelak-ovic B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 104: 12129-12134, 2007.
11. Han JS, Choi BS, Yang CW, Kim YS. Aldosterone-induced TGF-beta1 expression is regulated by mitogen-activated protein kinases and activator protein-1 in mesangial cells. J Korean Med Sci 24, Suppl: S195-S203, 2009.
12. Hocevar BA, Brown TL, Howe PH. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-indepen-dent pathway. EMBO J 18: 1345-1356, 1999.
13. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 10: 1492-1497, 1990.
14. Kim SJ, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem 264: 402-408, 1989.
15. Lee KY, Ito K, Hayashi R, Jazrawi EP, Barnes PJ, Adcock IM. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J Immunol 176: 603-615, 2006.
16. Li J, Zhang Z, Wang D, Wang Y, Li Y, Wu G. TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN. J Recept Signal Transduct Res 29: 280-285, 2009.
17. Li X, Wang H. Aristolochic acid nephropathy: what we know and what we have to do. Nephrology (Carlton) 9: 109-111, 2004.
18. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217, 2006.
19. Nakagawa K, Sugahara M, Yamasaki T, Kajiho H, Takahashi S, Hirayama J, Minami Y, Ohta Y, Watanabe T, Hata Y, Katada T, Nishina H. Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation. Biochem J 427: 237-245, 2010.
20. Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, Verbeelen D, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 73: 595-607, 2008.
21. Racusen LC, Monteil C, Sgrignoli A, Lucskay M, Marouillat S, Rhim JG, Morin JP. Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. J Lab Clin Med 129: 318-329, 1997.
22. Shaulian E. AP-1-the Jun proteins: oncogenes or tumor suppressors in disguise? Cell Signal 22: 894-899, 2010.
23. Sun BK, Kim JH, Nguyen HN, Oh S, Kim SY, Choi S, Choi HJ, Lee YJ, Song JJ. MEKK1/MEKK4 are responsible for TRAIL-induced JNK/ p38 phosphorylation. Oncol Rep 25: 537-544, 2011.
24. Tan XY, Zheng FL, Yang JH, Duan L, Li Y, Zhou QG. Effect of BMP-7 on the transdifferentiation of cultured human tubular epithelial cell induced by TGF-beta1. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26: 274-278, 2004.
25. Tang GY, Tian XF, Chen YP. Effects of aristolochic acid on human renal cells in vitro. Zhonghua Shen Zang Bing Za Zhi 18: 266-269, 2002.
26. Vesely PW, Staber PB, Hoefler G, Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat Res 682: 7-12, 2009.
27. Wang YY, Chen YP, Rui HL. Organic anion transporter system mediates the transport of aristolochic acid in tubular epithelial cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 31: 476-480, 2009.
28. Zhang C, Chen YP, Yang YF, Dong H. Protective effects of yishen ruanjian power on renal interstitial fibrosis in chronic aristolochic acid induced nephropathy rat model. Zhongguo Zhong Xi Yi Jie He Za Zhi 25: 714-718, 2005.
29. Zhang M, Tang GY, Rui HL, Chen YP. Hirsutella sinensis antagonized the effects of aristolochic acid on the human proximal tubular epithelial cells in vivo. Zhonghua Shen Zang Bing Za Zhi 22: 472-476, 2006.
30. Zhang Y, Neo SY, Wang X, Han J, Lin SC. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J Biol Chem 274: 35247-35254, 1999.
31. Zhou L, Fu P, Huang XR, Liu F, Chung AC, Lai KN, Lan HY. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am J Physiol Renal Physiol 298: F1006-F1017, 2010.
32. Zhu YF, Chen YP, Rui HL, Dong HR, Hu Z. Protective effects of Hirsutella sinensis on renal interstitial fibrosis: experiment with rat model of chronic aristolochic acid nephropathy. Zhonghua Yi Xue Za Zhi 87: 2667-2671, 2007.